The first quarter of 2026 reflected continued momentum in healthcare innovation, with $1.6 billion raised across 36 deals, an increase of 60% compared to Q1 2025, signaling sustained investor confidence in the sector. Deal volume remained consistent year over year, while total funding increased, pointing to larger average check sizes and a continued focus on scaling proven models. Early-stage companies accounted for 32% of funding, while late-stage companies captured 68%, as investors doubled down on market leaders demonstrating traction and measurable outcomes.

The report also spotlights five companies that closed significant Series A rounds. These companies are reshaping how healthcare is delivered, operated, and discovered.